PRELUDE CAPITAL MANAGEMENT, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$491,167
+112.1%
58,752
+530.3%
0.03%
+113.3%
Q2 2023$231,558
-80.6%
9,322
-90.8%
0.02%
-76.2%
Q4 2022$1,196,332
+409.1%
101,127
+71.6%
0.06%
+687.5%
Q3 2022$235,000
-47.0%
58,927
-43.4%
0.01%
-38.5%
Q2 2022$443,000
-56.1%
104,074
-1.8%
0.01%
-55.2%
Q1 2022$1,008,000
-49.7%
105,951
+0.4%
0.03%
-43.1%
Q4 2021$2,005,000
-37.7%
105,528
+9.0%
0.05%
-37.8%
Q3 2021$3,220,000
+5451.7%
96,782
+3126.1%
0.08%
+2633.3%
Q2 2020$58,000
-74.6%
3,000
-85.4%
0.00%
-66.7%
Q4 2019$228,000
+5600.0%
20,500
+3316.7%
0.01%
Q3 2019$4,000
-50.0%
600
-33.3%
0.00%
Q2 2019$8,0000.0%900
-10.0%
0.00%
Q1 2019$8,0001,000
+1269.9%
0.00%
Q4 2018$0
-100.0%
73
-6.4%
0.00%
Q2 2018$1,000
-99.2%
78
-99.3%
0.00%
-100.0%
Q3 2014$126,000
-20.8%
11,807
-30.2%
0.02%
-18.2%
Q2 2014$159,000
+8.9%
16,925
-20.2%
0.02%
+15.8%
Q1 2014$146,00021,2050.02%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders